Company Filing History:
Years Active: 2024
Title: Innovations of Mateusz Dasko in Medical Chemistry
Introduction
Mateusz Dasko is an accomplished inventor based in Pruszcz Gdanski, Poland. He has made significant contributions to the field of medical chemistry, particularly through his innovative work on sulfamate derivatives. His research focuses on the development of new compounds that have potential medical applications, especially in cancer therapy.
Latest Patents
Mateusz Dasko holds 1 patent for his invention titled "Sulfamate derivatives of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenol." This patent details the medical use of these derivatives as agents with properties of a steroid sulfatase inhibitor and/or an estrogen receptor modulator. The invention emphasizes the potential of these compounds as antimicrobial medicaments and their specific application in cancer therapy. The process for preparing these new compounds involves using derivatives of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenol as intermediate products.
Career Highlights
Mateusz Dasko is affiliated with the Gdansk University of Technology, where he continues to advance his research in medical chemistry. His work has garnered attention for its innovative approach to developing new therapeutic agents. Dasko's contributions are paving the way for future advancements in cancer treatment and other medical applications.
Collaborations
Mateusz has collaborated with notable colleagues such as Sebastian Demkowicz and Janusz Rachon. These partnerships have enhanced the scope and impact of his research, leading to significant advancements in the field.
Conclusion
Mateusz Dasko's innovative work in the development of sulfamate derivatives showcases his commitment to advancing medical chemistry. His contributions have the potential to significantly impact cancer therapy and other medical fields.